Browse wide-ranging research at the frontiers of neuroscience supported by Wu Tsai Neurosciences Institute grants, awards, and training fellowships.
Projects
Rejuvenating sleep to enhance brain resilience with age
Sleep is a critical behavioral state that fulfills essential needs for health, including clearing waste products (e.g., protein aggregates) from the brain. But sleep is not everlasting. As humans age, sleep quality strikingly deteriorates, and this decline is associated with dementias (e.g., Alzheimer’s disease).
Elucidating the role of alternative polyadenylation in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)
With an aging population, neurodegenerative disorders contribute increasingly to our global health burden with no cure or effective treatments. Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two neurodegenerative disorders that are distinct in clinical presentation (ALS impairs movement/breathing, whereas FTD impairs behavior/cognition).
Neuron-glia interactions in regulating protein aggregation in human cell models.
There is one characteristic of all neurodegenerative diseases: the accumulation and aggregation of abnormal proteins in the patient’s brain. These aggregations are thought to induce neuronal cell death and brain degeneration.
The origin of neurodegeneration: insight from a unique colonial chordate
With an aging population, neurodegenerative disorders contribute increasingly to our global health burden with no cure or effective treatments. Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two neurodegenerative disorders that are distinct in clinical presentation (ALS impairs movement/breathing, whereas FTD impairs behavior/cognition).
Determining the role of circadian transcriptional control in myelin-forming precursors in neurodegeneration
The causes of neurodegenerative disorders like multiple sclerosis or Alzheimer’s disease are incompletely understood, hindering our ability to gain precise diagnoses and design effective therapeutics. Understanding how the circadian rhythms regulate myelin-forming precursors will impart unique insights into normal and aberrant myelination and will have a positive impact on developing therapeutic strategies to restructure myelin.
NeuroChoice Initiative (Phase 2)
Stanford NeuroTechnology Initiative (Phase 2)
Our goal is to develop the next generation of neural interfaces that match the resolution and performance of the biological circuitry. We will focus on two signature efforts to spearhead the necessary advances: high-density wire bundles for electrical recording and stimulation, and analog and digital bi-directional retinal prostheses for restoration of vision.
Stanford Brain Rejuvenation Project (Phase 2)
The Stanford Brain Rejuvenation Project is an initiative by leading aging researchers, neuroscientists, chemists, and engineers to understand the basis of brain aging and rejuvenation and how they relate to neurodegeneration.
Neuro-circuit interventional research consortium for understanding the brain and improving treatment
Combining a detailed understanding of brain circuits with technology that modulates neural activity to develop improved ways of treating mental health conditions.
NeuroVision Initiative
The goal is to forge an inter-disciplinary collaboration between physicists, biologists, chemists, and translational medical scientists by inventing new ways of visualizing the brain, from individual molecules to neuronal circuits to entire brain regions, from a normally functioning neuron to a diseased brain.
The NeuroFab: The hub for new ideas in neuro-engineering
Creating an incubator for next-generation neural interface platforms.
Brain-machine interfaces: Science, engineering, and application
Developing technology to interface with the brain and create intelligent prosthetics.
Stroke Collaborative Action Network
Breaches barriers in our understanding of stroke to develop therapies and improve stroke recovery.
NeuroChoice: Optimizing Choice - from neuroscience to public policy
NeuroPlant Initiative
The NeuroPlant Initiative aims to leverage a botanical armamentarium to manipulate the brain — by building a pipeline to explore chemicals synthesized in plants as potential new treatments for neurological disease and as a window into the chemistry of the brain.
Neurodevelopment Initiative
Investigating how the brain develops from infancy to adulthood across species, focusing on how the interplay between structural development, functional development, experience and affect brain computations and ultimately behavior.
Stanford Brain Organogenesis Program (Phase 1)
Developing brain organoids – three dimensional brain tissues grown in the lab – to study human brain development, evolution and neuropsychiatric disorders.
Neuro-omics Initiative (Phase 1)
Creating new tools to help neuroscientists bridge the study of genes and proteins operating in the brain to the study of brain circuits and systems, which could lead to a deeper understanding of brain function and disease.
Stanford Brain Organogenesis Program (Phase 2)
Developing brain organoids and assembloids – three dimensional brain tissues grown in the lab – to study human brain development, evolution and neuropsychiatric disorders.
Neuro-Omics Initiative (Phase 2)
Creating new tools to help neuroscientists bridge the study of genes and proteins operating in the brain to the study of brain circuits and systems, which could lead to a deeper understanding of brain function and disease.